Log In
Print
BCIQ
Print
Print this Print this
 

MPI-676

  Manage Alerts
Collapse Summary General Information
Company Meditrina Pharmaceuticals Inc.
DescriptionAnastrozole-based aromatase inhibitor
Molecular Target Aromatase
Mechanism of ActionAromatase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationEndometriosis
Indication DetailsTreat endometriosis
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today